Pfizer And Astellas Ink Co-promotion Agreement For Hypertension And Cholesterol Combo Drug Caduet In Japan

TOKYO - Pfizer and Astellas Pharma have signed a co-promotion agreement for combination drug, Caduet (amlodipine and atorvastatin) for local Japanese distribution to treat both hypertension and hypercholesterolemia, the first combination drug for the two treatments, the two companies announced Aug. 26